Life360, Inc. — Director's Dealing 2021

Dec 14, 2021

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity: Life360, Inc.

ARBN: 629 412 942

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

We (the entity) give ASX the following the director for the purposes of section	information under listing rule 3.19A.2 and as agent for 205G of the Corporations Act.
Name of Director	James Synge
Date of last notice	8 December 2021

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	‐
Date of change	8 December 2021 (PST)
No. of securities held prior to change	 1,441,041 Chess Depositary Interests (CDIs)  15,476 Shares of Common Stock (Shares)(equivalent to 46,428 CDIs)  193,137 CDIs held by ICCA Labs, LLC1  211,720 CDIs held by Stynge Pty Ltd ATF Sandy Bay Trust.  1,411 Restricted Stock Units (RSUs)  12,203 Options over Shares (Options)

1 James Synge is a member of ICCA Labs, LLC, an entity that holds Life360 CDIs. The number of CDIs attributable to James Synge by reason of his membership interest in ICCA Labs, LLC is 193,137.

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Class	Shares & RSUs
Number acquired	470 Shares
Number disposed	470 RSUs (having vested)
Value/Consideration Note: If consideration is non‐cash, provide details and estimated valuation	Shares are issued following the vesting and settlement of 470 RSUs which were granted in lieu of the payment of Director and Committee fees2
No. of securities held after change	 1,441,041 CDIs  15,946 Shares (equivalent to 47,838 CDIs)  193,137 CDIs held by ICCA Labs, LLC  211,720 CDIs held by Stynge Pty Ltd ATF Sandy Bay Trust.  941 RSUs  12,203 Options
Nature of change Example: on‐market trade, off‐market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy‐back	Issue of Shares following the vesting and settlement of RSUs.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A

2 As per Appendix 3Y lodged on 7 May 2021, 1,881 RSUs were granted in lieu of the payment of US$25,110 of Director and Committee Fees. RSUs vest and are settled quarterly.

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Interest disposed	N/A
Value/Consideration Note: If consideration is non‐cash, provide details and an estimated valuation	N/A
Interest after change	N/A

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No.
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3